Brief: Brickell Biotech Reports Q1 2022 Results And Provides Corporate Update
May 12 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* BRICKELL BIOTECH- EXPECTS CASH, CASH EQUIVALENTS AS OF
MARCH 31,
2022,PAYMENTS UNDER DEAL WITH BOTANIX TO SUPPORT OPERATIONS FOR
AT LEAST NEXT 12 MONTHS
* BRICKELL BIOTECH INC - QTRLY LOSS PER SHARE $0.08
Source text for Eikon: ID:nGNX3Clthh
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx